---
figid: PMC9496100__biomolecules-12-01310-g004
figtitle: Ginsenoside and Its Therapeutic Potential for Cognitive Impairment
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9496100
filename: biomolecules-12-01310-g004.jpg
figlink: /pmc/articles/PMC9496100/figure/biomolecules-12-01310-f004/
number: F4
caption: 'Molecular mechanisms of regulating CREB/BDNF signaling pathway by ginsenosides
  in treating cognitive impairment in the pathological model. CREB/BDNF signaling
  pathway can be activated by ginsenosides in multiple ways: (1) Rd, Rb1, PF 11, and
  Rg1 promote the expression of TrKB. (2) Rg1 and Rd increase the expression of MEK1/2
  and PI3K, respectively. (3) Rg1 activates ERK, PKA, CREB, and CaMKII. (3) Rd, Rb1,
  Rg1, Rg3, Rg5, F1, and PF11 can promote both CREB and BDNF. All ginsenosides play
  a positive role in stimulating key factors in CREB/BDNF pathway to further improve
  synaptic plasticity and decrease Aβ deposition and tau hyperphosphorylation.'
papertitle: Ginsenoside and Its Therapeutic Potential for Cognitive Impairment.
reftext: Hui Feng, et al. Biomolecules. 2022 Sep;12(9):1310.
year: '2022'
doi: 10.3390/biom12091310
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: ginsenosides | cognitive impairment | pharmacological properties | apoptosis
  | inflammation
automl_pathway: 0.9534574
figid_alias: PMC9496100__F4
figtype: Figure
redirect_from: /figures/PMC9496100__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9496100__biomolecules-12-01310-g004.html
  '@type': Dataset
  description: 'Molecular mechanisms of regulating CREB/BDNF signaling pathway by
    ginsenosides in treating cognitive impairment in the pathological model. CREB/BDNF
    signaling pathway can be activated by ginsenosides in multiple ways: (1) Rd, Rb1,
    PF 11, and Rg1 promote the expression of TrKB. (2) Rg1 and Rd increase the expression
    of MEK1/2 and PI3K, respectively. (3) Rg1 activates ERK, PKA, CREB, and CaMKII.
    (3) Rd, Rb1, Rg1, Rg3, Rg5, F1, and PF11 can promote both CREB and BDNF. All ginsenosides
    play a positive role in stimulating key factors in CREB/BDNF pathway to further
    improve synaptic plasticity and decrease Aβ deposition and tau hyperphosphorylation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Akt
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Rbf
  - Erk7
  - rl
  - ab
  - Appl
  - tau
  - MKP-4
  - p38b
  - CrebB
  - CrebA
  - CaMKII
  - BDNF
  - BDNF-AS
  - NTRK2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - RB1
  - RBM45
  - EPHB2
  - MAPK1
  - MAPK3
  - APP
  - SUCLA2
  - MAPT
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - CAMK2G
---
